Cytogenix (fka CYGX)

[arnold]

bigworld. we are waiting.

December 27, 2005,
GE Healthcare's Fast Trak BioDefense group has a diverse staff of highly qualified technical and regulatory experts who will collaborate with CytoGenix in seeking, obtaining and executing bio-defense related federal contracts.

2005 will be a breakout year.

The Company's research and development projects will result in clinically testable products. We have already discussed the anti-herpes and anti-microbial products above. We will complete our studies on our anti-inflammatory product, CY302, and submit the pre-IND briefing document to the FDA. Thus, we expect to have two and perhaps, three products in clinical trials next year.